Results 221 to 230 of about 1,133,085 (338)
From proposal to compromise: the TRIPS waiver debate and the crisis of WTO decision-making. [PDF]
Global HealthSyam N, Abbas MZ.
europepmc +1 more source
Resources as dual sources of advantage: Implications for valuing entrepreneurial‐firm patents
, 2013 David H. Hsu, Rosemarie H. Ziedonis
semanticscholar +1 more source
Molecular Oncology, EarlyView.Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser +14 more
wiley +1 more source
Public values in public R&D through natural language processing. [PDF]
Sci RepJang H, Roh T, Yoon B.
europepmc +1 more source
A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression
Molecular Oncology, EarlyView.Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak +8 more
wiley +1 more source
The impact of carbon emissions trading on innovation bubbles in manufacturing enterprises. [PDF]
Sci RepLyu Z, Li G.
europepmc +1 more source
Creative Class Competition and Innovation in the Absence of Patent Protection
, 2018 Amitrajeet A. Batabyal
openalex
Molecular Oncology, EarlyView.Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié +16 more
wiley +1 more source